lifestyle.thedailyhaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Protagenic Therapeutics, Inc.
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
March 17, 2026
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
March 10, 2026
Results from Phase 1 Multiple-Dose Study of PT00114
December 9, 2025